UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000011732 |
|---|---|
| Receipt number | R000013712 |
| Scientific Title | To administer the extract Salacia plant supplementation to Japanese adult male for 4 weeks for analyzing the effectiveness of the immune function and evaluate the effectiveness of an improvement in immune strength through this study.Study design: a double-blind placebo controlled trial. |
| Date of disclosure of the study information | 2013/09/12 |
| Last modified on | 2019/05/14 09:09:38 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/09/12 14:53:42 | ||
| 2 | Update | 2013/12/16 10:04:17 | Results |
|
| 3 | Update | 2013/12/24 17:01:04 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Results |
|
| 4 | Update | 2013/12/24 17:02:09 | Recruitment status |
|
| 5 | Update | 2016/07/13 10:11:40 | Name of primary person or sponsor Organization |
|
| 6 | Update | 2016/08/08 11:04:58 | Condition Condition Classification by specialty Basic objectives2 Key secondary outcomes Key secondary outcomes |
|
| 7 | Update | 2016/08/08 11:06:40 | Randomization unit Purpose of intervention |
|
| 8 | Update | 2019/02/28 16:06:42 | Publication of results URL related to results and publications |
|
| 9 | Update | 2019/03/05 11:52:17 | Publication of results URL related to results and publications Results Results |
|
| 10 | Update | 2019/05/07 14:06:56 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 11 | Update | 2019/05/13 12:47:12 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 12 | Update | 2019/05/13 13:02:57 | Date of IRB Anticipated trial start date |
|
| 13 | Update | 2019/05/14 09:09:38 | Number of participants that the trial has enrolled |
